PE20010216A1 - Procedimiento para preparar derivados de 10,11-metanobenzosuberano - Google Patents
Procedimiento para preparar derivados de 10,11-metanobenzosuberanoInfo
- Publication number
- PE20010216A1 PE20010216A1 PE2000000541A PE0005412000A PE20010216A1 PE 20010216 A1 PE20010216 A1 PE 20010216A1 PE 2000000541 A PE2000000541 A PE 2000000541A PE 0005412000 A PE0005412000 A PE 0005412000A PE 20010216 A1 PE20010216 A1 PE 20010216A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- reacting
- formula
- methanobenzosuberan
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 11
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 abstract 1
- 239000012038 nucleophile Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Catalysts (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA PREPARAR DERIVADOS DE 10,11-METANOBENZOSUBERANO DE FORMULA I, DONDE: A ES -CH2-CH2-, -CH2-CHRa-CH2-, -CH2-CHRa-CH2-CH2; Ra ES OH; R1 Y R2 SON H, F, Cl, Br; R3 ES HETEROARILO, FENILO OPCIONALMENTE SUSTITUIDO CON F, Cl, Br, CF3, CN, NO2, OCHF2 QUE COMPRENDE: a) REACCIONAR UN COMPUESTO (4) CON UNA FUENTE DE NUCLEOFILOS PARA FORMAR UN COMPUESTO (5); b) REACCIONAR UN COMPUESTO (5) CON PIRAZINA PARA FORMAR UN COMPUESTO (6); c) REDUCIR EL COMPUESTO (6) PARA FORMAR UN COMPUESTO (8); d) REACCIONAR UN COMPUESTO (8) CON i) UN COMPUESTO EPOXIDICO DE FORMULA (9) ii)UN COMPUESTO HALO DE FORMULA X1-(CH2)m-O-R3, X1 ES HALO, m ES 2-4; e)FORMAR UNA SAL DEL COMPUESTO (9) o (10). TAMBIEN SE REFIERE A LA PREPARACION DE COMPUESTOS INTERMEDIOS. UN COMPUESTO PREFERIDO ES TRICLORHIDRATO DE (2R)-ANTI-5-{3-[4-(10,11-DIFLUOROMETANODIBENZOSUBER-5-IL)PIPERAZIN-1-IL]-2-HIDROXIPROPOXI}QUINOLINA HIDRATO CRISTALINO, HIDRATO I, QUE SE CARACTERIZA POR SU PATRON DE DIFRACCION DE RAYOS X. LOS COMPUESTOS PUEDEN SER UTILES PARA EL TRATAMIENTO DEL CANCER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13728399P | 1999-06-03 | 1999-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010216A1 true PE20010216A1 (es) | 2001-02-27 |
Family
ID=22476642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000541A PE20010216A1 (es) | 1999-06-03 | 2000-06-01 | Procedimiento para preparar derivados de 10,11-metanobenzosuberano |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6521755B1 (es) |
| EP (1) | EP1189887A2 (es) |
| JP (1) | JP2003501421A (es) |
| KR (1) | KR100692351B1 (es) |
| AR (1) | AR037068A1 (es) |
| AU (1) | AU5123300A (es) |
| BR (1) | BR0011559A (es) |
| CA (1) | CA2378735A1 (es) |
| CO (1) | CO5170530A1 (es) |
| EG (1) | EG24072A (es) |
| HU (1) | HUP0203421A3 (es) |
| IL (2) | IL146810A0 (es) |
| MX (1) | MXPA01012296A (es) |
| MY (1) | MY123517A (es) |
| PE (1) | PE20010216A1 (es) |
| SV (1) | SV2002000088A (es) |
| TW (1) | TWI267511B (es) |
| WO (1) | WO2000075121A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60014386T2 (de) * | 1999-06-03 | 2005-10-13 | Eli Lilly And Co., Indianapolis | Verfahren zur herstellung von 10,11methanodibenzosuberanderivaten |
| AU2001269708A1 (en) * | 2000-07-18 | 2002-01-30 | Eli Lilly And Company | Novel method of use of multidrug resistance modulators |
| JP2004527552A (ja) | 2001-04-25 | 2004-09-09 | イーライ・リリー・アンド・カンパニー | （２ｒ）−アンチ−５−｛３−［４−（１０，１１−ジフルオロメタノジベンゾスベラ−５−イル）ピペラジン−１−イル］−２−ヒドロキシプロポキシ｝キノリンの新規な塩および結晶形態 |
| US11930815B1 (en) | 2023-08-29 | 2024-03-19 | King Faisal University | 3,3′-(piperazine-1,4-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as insecticidal agent |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| JPS6147466A (ja) * | 1984-08-10 | 1986-03-07 | Dainippon Pharmaceut Co Ltd | アミン誘導体 |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5643909A (en) | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
-
2000
- 2000-05-22 TW TW089109803A patent/TWI267511B/zh not_active IP Right Cessation
- 2000-05-23 MY MYPI20002248A patent/MY123517A/en unknown
- 2000-05-26 KR KR1020017015505A patent/KR100692351B1/ko not_active Expired - Fee Related
- 2000-05-26 BR BR0011559-2A patent/BR0011559A/pt not_active Application Discontinuation
- 2000-05-26 HU HU0203421A patent/HUP0203421A3/hu unknown
- 2000-05-26 SV SV2000000088A patent/SV2002000088A/es unknown
- 2000-05-26 IL IL14681000A patent/IL146810A0/xx active IP Right Grant
- 2000-05-26 US US09/980,847 patent/US6521755B1/en not_active Expired - Fee Related
- 2000-05-26 EP EP00935832A patent/EP1189887A2/en not_active Withdrawn
- 2000-05-26 AU AU51233/00A patent/AU5123300A/en not_active Abandoned
- 2000-05-26 CA CA002378735A patent/CA2378735A1/en not_active Abandoned
- 2000-05-26 MX MXPA01012296A patent/MXPA01012296A/es unknown
- 2000-05-26 JP JP2001501602A patent/JP2003501421A/ja active Pending
- 2000-05-26 WO PCT/US2000/009826 patent/WO2000075121A2/en not_active Ceased
- 2000-05-27 EG EG20000680A patent/EG24072A/xx active
- 2000-05-29 CO CO00039595A patent/CO5170530A1/es not_active Application Discontinuation
- 2000-05-31 AR ARP000102679A patent/AR037068A1/es unknown
- 2000-06-01 PE PE2000000541A patent/PE20010216A1/es not_active Application Discontinuation
-
2001
- 2001-11-29 IL IL146810A patent/IL146810A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1189887A2 (en) | 2002-03-27 |
| HUP0203421A2 (hu) | 2003-02-28 |
| TWI267511B (en) | 2006-12-01 |
| SV2002000088A (es) | 2002-01-23 |
| KR20020038587A (ko) | 2002-05-23 |
| AU5123300A (en) | 2000-12-28 |
| IL146810A (en) | 2007-06-03 |
| KR100692351B1 (ko) | 2007-03-09 |
| WO2000075121A2 (en) | 2000-12-14 |
| EG24072A (en) | 2008-05-11 |
| BR0011559A (pt) | 2002-02-26 |
| CA2378735A1 (en) | 2000-12-14 |
| MY123517A (en) | 2006-05-31 |
| HUP0203421A3 (en) | 2003-05-28 |
| JP2003501421A (ja) | 2003-01-14 |
| IL146810A0 (en) | 2002-07-25 |
| CO5170530A1 (es) | 2002-06-27 |
| WO2000075121A3 (en) | 2001-04-26 |
| US6521755B1 (en) | 2003-02-18 |
| MXPA01012296A (es) | 2002-07-30 |
| AR037068A1 (es) | 2004-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2353616C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| PE20020506A1 (es) | Derivados de pirazol fusionados como inhibidores de la proteina cinasa | |
| YU8703A (sh) | Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1 | |
| PE20030612A1 (es) | Benzoimidazoles | |
| DE60135742D1 (de) | Substituierte phenylpropionsäure-derivate | |
| ATE454152T1 (de) | 2-aminopyrimidin-derivate als raf-kinase-hemmer | |
| DE60237145D1 (de) | Chinazolinderivate | |
| LU92113I2 (fr) | Perampanel et ses dérivés pharmaceutiquement acceptables (FYCOMPA) | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| PE20030574A1 (es) | N-[benzoil]heteroarilsulfonamida como agentes antineoplasicos | |
| CY1111980T1 (el) | Παραγωγα του αμιδιου τα οποια φερουν ενα υποκαταστατο του κυκλοπροπυλαμινοκαρβονυλιου και χρησιμευουν ως αναστολεις κυτταροκινης | |
| EA200300982A1 (ru) | Гетероциклические производные для лечения рака и других пролиферативных заболеваний | |
| CY1108061T1 (el) | Παραγωγα κιναζολινης ως src αναστολεις κινασης τυροσινης | |
| BR0312439A (pt) | Processo para preparação de derivados de ácido 5-(1,3-oxazol-2-il)benzóico | |
| PE20061490A1 (es) | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 | |
| EA200400475A1 (ru) | Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли | |
| EA200600330A1 (ru) | Замещённые имидазопиримидины для предупреждения и лечения рака | |
| ATE296815T1 (de) | Substituierte benzylthiazolidin-2,4-dion derivate | |
| NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
| ATE453389T1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| PE20010216A1 (es) | Procedimiento para preparar derivados de 10,11-metanobenzosuberano | |
| EA200200302A1 (ru) | Полиморфная соль | |
| EP1253139A3 (en) | Multioligoanilinated fullerenes | |
| ATE181734T1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| JP2007507467A5 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |